276 related articles for article (PubMed ID: 8035875)
21. Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution.
Tuuttila A; Morgunova E; Bergmann U; Lindqvist Y; Maskos K; Fernandez-Catalan C; Bode W; Tryggvason K; Schneider G
J Mol Biol; 1998 Dec; 284(4):1133-40. PubMed ID: 9837731
[TBL] [Abstract][Full Text] [Related]
22. Structure and kinetics of phosphonopyruvate hydrolase from Variovorax sp. Pal2: new insight into the divergence of catalysis within the PEP mutase/isocitrate lyase superfamily.
Chen CC; Han Y; Niu W; Kulakova AN; Howard A; Quinn JP; Dunaway-Mariano D; Herzberg O
Biochemistry; 2006 Sep; 45(38):11491-504. PubMed ID: 16981709
[TBL] [Abstract][Full Text] [Related]
23. Calpain silencing by a reversible intrinsic mechanism.
Moldoveanu T; Hosfield CM; Lim D; Jia Z; Davies PL
Nat Struct Biol; 2003 May; 10(5):371-8. PubMed ID: 12665854
[TBL] [Abstract][Full Text] [Related]
24. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.
Thornberry NA; Bull HG; Calaycay JR; Chapman KT; Howard AD; Kostura MJ; Miller DK; Molineaux SM; Weidner JR; Aunins J
Nature; 1992 Apr; 356(6372):768-74. PubMed ID: 1574116
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of a novel mid-gut procarboxypeptidase from the cotton pest Helicoverpa armigera.
Estébanez-Perpiñá E; Bayés A; Vendrell J; Jongsma MA; Bown DP; Gatehouse JA; Huber R; Bode W; Avilés FX; Reverter D
J Mol Biol; 2001 Oct; 313(3):629-38. PubMed ID: 11676544
[TBL] [Abstract][Full Text] [Related]
26. Mch3, a novel human apoptotic cysteine protease highly related to CPP32.
Fernandes-Alnemri T; Takahashi A; Armstrong R; Krebs J; Fritz L; Tomaselli KJ; Wang L; Yu Z; Croce CM; Salveson G
Cancer Res; 1995 Dec; 55(24):6045-52. PubMed ID: 8521391
[TBL] [Abstract][Full Text] [Related]
27. The 2.15 A crystal structure of a triple mutant plastocyanin from the cyanobacterium Synechocystis sp. PCC 6803.
Romero A; De la Cerda B; Varela PF; Navarro JA; Hervás M; De la Rosa MA
J Mol Biol; 1998 Jan; 275(2):327-36. PubMed ID: 9466912
[TBL] [Abstract][Full Text] [Related]
28. Crystal structures of human DNA polymerase beta complexed with DNA: implications for catalytic mechanism, processivity, and fidelity.
Pelletier H; Sawaya MR; Wolfle W; Wilson SH; Kraut J
Biochemistry; 1996 Oct; 35(39):12742-61. PubMed ID: 8841118
[TBL] [Abstract][Full Text] [Related]
29. B cell receptor cross-linking prevents Fas-induced cell death by inactivating the IL-1 beta-converting enzyme protease and regulating Bcl-2/Bcl-x expression.
Brás A; Martinez-A C; Baixeras E
J Immunol; 1997 Oct; 159(7):3168-77. PubMed ID: 9317114
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of a fluorogenic interleukin-1 beta converting enzyme substrate based on resonance energy transfer.
Pennington MW; Thornberry NA
Pept Res; 1994; 7(2):72-6. PubMed ID: 8012123
[TBL] [Abstract][Full Text] [Related]
31. Inflammation. Key mediator takes shape.
Thornberry NA
Nature; 1994 Jul; 370(6487):251-2. PubMed ID: 8035871
[No Abstract] [Full Text] [Related]
32. The three-dimensional structure of human interleukin-1 beta refined to 2.0 A resolution.
Priestle JP; Schär HP; Grütter MG
Prog Clin Biol Res; 1990; 349():297-307. PubMed ID: 2144642
[No Abstract] [Full Text] [Related]
33. X-ray structural studies of the cytokine interleukin 1-beta.
Treharne AC; Ohlendorf DH; Weber PC; Wendoloski JJ; Salemme FR
Prog Clin Biol Res; 1990; 349():309-19. PubMed ID: 2144643
[TBL] [Abstract][Full Text] [Related]
34. Probing the role of interleukin-1 beta convertase in interleukin-1 beta secretion.
Howard AD; Chartrain N; Ding GF; Kostura MJ; Limjuco G; Schmidt JA; Tocci MJ
Agents Actions Suppl; 1991; 35():77-83. PubMed ID: 1781424
[TBL] [Abstract][Full Text] [Related]
35. Production of active human interleukin-1 beta-converting enzyme in a baculovirus expression system.
Wang XM; Helaszek CT; Winter LA; Lirette RP; Dixon DC; Ciccarelli RB; Kelley MM; Malinowski JJ; Simmons SJ; Huston EE
Gene; 1994 Aug; 145(2):273-7. PubMed ID: 8056342
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-1 beta converting enzyme requires oligomerization for activity of processed forms in vivo.
Gu Y; Wu J; Faucheu C; Lalanne JL; Diu A; Livingston DJ; Su MS
EMBO J; 1995 May; 14(9):1923-31. PubMed ID: 7743999
[TBL] [Abstract][Full Text] [Related]
37. The PepSY domain: a regulator of peptidase activity in the microbial environment?
Yeats C; Rawlings ND; Bateman A
Trends Biochem Sci; 2004 Apr; 29(4):169-72. PubMed ID: 15124630
[No Abstract] [Full Text] [Related]
38. An intact SAM-dependent methyltransferase fold is encoded by the human endothelin-converting enzyme-2 gene.
Tempel W; Wu H; Dombrovsky L; Zeng H; Loppnau P; Zhu H; Plotnikov AN; Bochkarev A
Proteins; 2009 Feb; 74(3):789-93. PubMed ID: 19089949
[No Abstract] [Full Text] [Related]
39. Purification of interleukin-1 beta converting enzyme, the protease that cleaves the interleukin-1 beta precursor.
Kronheim SR; Mumma A; Greenstreet T; Glackin PJ; Van Ness K; March CJ; Black RA
Arch Biochem Biophys; 1992 Aug; 296(2):698-703. PubMed ID: 1321594
[TBL] [Abstract][Full Text] [Related]
40. The NMR structure of the inhibited catalytic domain of human stromelysin-1.
Gooley PR; O'Connell JF; Marcy AI; Cuca GC; Salowe SP; Bush BL; Hermes JD; Esser CK; Hagmann WK; Springer JP
Nat Struct Biol; 1994 Feb; 1(2):111-8. PubMed ID: 7656014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
